What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement

Revisions to USP are Here

The revisions to the USP <797> standards are now in effect as of November 1, 2023 for pharmacies that create Category 3 compounded sterile preparations. These pharmacies will need to adapt to achieve compliance with USP <797>, and doing so will require a great deal of time and expense. Thankfully, AIS is ready to meet these revised standards. Are you?

1698939864872.jpg


Click the link to learn more about how AIS meets or exceeds industry standards or contact us here. We’re here to help.

AIS Healthcare

AIS Healthcare News & Announcements

AIS Healthcare is a leader in targeted drug delivery and infusion care, empowering transformative impact across the care continuum.

10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

This post is related to:

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from Revisions to USP are Here

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe